| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.3M | — | +8.4% |
| Gross Profit | $16.6M | — | +10.8% |
| R&D Expense | $5.8M | — | +28.1% |
| SG&A Expense | $6.9M | — | +54.5% |
| Operating Income | -$3.6M | — | -741.0% |
| Pre-tax Income | -$4.5M | — | -292.5% |
| Income Tax | $34K | — | +47.8% |
| Net Income | -$4.5M | — | -188.9% |
| EPS (Basic) | $0.66 | — | +512.5% |
| EPS (Diluted) | $0.65 | — | +506.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.3M | -22.5% | -45.1% |
| Accounts Receivable | $15.7M | -37.3% | +30.0% |
| Inventory | $12.5M | +62.3% | -17.0% |
| Current Assets | $53.3M | -16.9% | -19.5% |
| Total Assets | $84.2M | -10.3% | -9.5% |
| Current Liabilities | $52.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.7M | — | +149.5% |
| Capital Expenditures | $131K | — | +309.4% |
| Investing Cash Flow | -$3.9M | — | -288.9% |
| Financing Cash Flow | -$3.3M | — | -8035.7% |
| Free Cash Flow | $1.6M | — | +145.3% |
| -11.7% |
| Total Liabilities | $109.6M | +12.0% | +3.4% |
| Stockholders' Equity | -$25.4M | -528.5% | -95.6% |